Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
Bristol-Myers Squibb’s Oncology Segment in 2Q15
Yahoo/Market Realist
Wed, 09/23/15 - 09:53 pm
Bristol-Myers Squibb
oncology
Baxalta Said in Talks to Buy Ariad to Boost Cancer Offerings
Bloomberg
Fri, 08/28/15 - 05:59 pm
Baxalta
Ariad Pharmaceuticals
M&A
oncology
AstraZeneca’s Oncology Segment: How Did It Perform in 2Q15?
Yahoo/Market Realist
Fri, 08/28/15 - 08:12 am
AstraZeneca
oncology
AstraZeneca Oncology Partnerships To Help Recover Sales
Bidness ETC
Tue, 08/25/15 - 09:43 am
AstraZeneca
oncology
Pfizer
Peregrine Pharmaceuticals
Heptares Therapeutics
Mirati Therapeutics
Juno Therapeutics
GlaxoSmithKline Deal Unlikely To Help Novartis AG Top Oncology Sales
Bidness, ETC
Mon, 08/17/15 - 11:11 am
GSK
Novartis
Roche
oncology
AstraZeneca Has An Oncology Pipeline Packed With Potential
Seeking Alpha
Sun, 07/19/15 - 05:51 pm
AstraZeneca
oncology
AZD9291
Lynparza
Novartis playing catch-up in cancer? Not us, says top oncology exec
Fierce Pharma Marketing
Wed, 06/24/15 - 08:35 am
Novartis
oncology
cancer
immuno-oncology
Roche Builds a Wide Moat With Dominant Oncology and Diagnostics Franchises
Morningstar
Mon, 06/8/15 - 10:07 pm
Roche
oncology
diagnostics
Roche unchallenged at top of cancer sellers, but Celgene could fight Novartis for No. 2
Fierce Pharma
Wed, 06/3/15 - 12:26 pm
Roche
Celgene
oncology
Novartis
Pfizer gaining market share in oncology: CEO
CNBC
Mon, 06/1/15 - 07:46 pm
Pfizer
oncology
Pharma CEOs
Ian Read
ASCO
Merck KGaA poaches Sanofi oncology exec Zhen Su
Fierce Biotech
Fri, 05/29/15 - 12:18 pm
Merck KGaA
Sanofi
oncology
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
GSK's Curious Oncology Research Position -- A Recipe For Failure?
Forbes
Tue, 05/12/15 - 10:17 am
GSK
R&D
oncology
Novartis
Is Novartis an Up-and-Coming Oncology Powerhouse?
Yahoo/Market Realist
Wed, 05/6/15 - 08:51 am
Novartis
oncology
cancer
Novartis Looks Much Healthier
Barron's
Sat, 05/2/15 - 01:11 pm
Novartis
oncology
GSK
Eli Lilly
US pharma market value projected to be $550 billion in five years
Medical Marketing and Media
Wed, 03/18/15 - 08:10 pm
Pharma
PBMs
diabetes
oncology
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal To Restructure
Bidness Etc.
Mon, 03/2/15 - 08:11 am
Novartis
GSK
M&A
vaccines
oncology
Sanofi to chop 100 US jobs in oncology R&D, Genzyme reorg
BioPharma Dive
Wed, 02/11/15 - 05:41 pm
Sanofi
reorganization
layoffs
R&D
Genzyme
oncology
G1 Therapeutics banks $33M to cut in on a blockbuster oncology race
Fierce Biotech
Thu, 02/5/15 - 05:00 pm
G1 Therapeutics
oncology
G1T28
Gilead Sciences: What Its New Hire Means for Its Cancer Pipeline
Barron's
Mon, 12/15/14 - 03:29 pm
Gilead Sciences
cancer
R&D
oncology
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »